Sutro Biopharma, Inc.

Sutro Biopharma, Inc. financial statements

Sutro Biopharma, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 102.48M10-K
Net income−USD 191.09M10-K
Cash and equivalentsUSD 58.13M10-Q
Total debtUSD 15.67MEODHD

Sutro Biopharma, Inc. financials on 6ix · Sutro Biopharma, Inc. on 6ix